ID   PYRH_ECOLI              Reviewed;         241 AA.
AC   P0A7E9; P29464;
DT   07-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   15-MAR-2017, entry version 105.
DE   RecName: Full=Uridylate kinase;
DE            Short=UK;
DE            EC=2.7.4.22;
DE   AltName: Full=Uridine monophosphate kinase;
DE            Short=UMP kinase;
DE            Short=UMPK;
GN   Name=pyrH; Synonyms=smbA; OrderedLocusNames=b0171, JW0166;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND CHARACTERIZATION.
RC   STRAIN=K12;
RA   Smallshaw J.E., Kelln R.A.;
RT   "Cloning, nucleotide sequence and expression of the Escherichia coli
RT   K-12 pyrH gene encoding UMP kinase.";
RL   Life Sci. Adv. (Genet.) 11:59-65(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1447125; DOI=10.1128/jb.174.23.7517-7526.1992;
RA   Yamanaka K., Ogura T., Niki H., Hiraga S.;
RT   "Identification and characterization of the smbA gene, a suppressor of
RT   the mukB null mutant of Escherichia coli.";
RL   J. Bacteriol. 174:7517-7526(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 2-8, FUNCTION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, CHARACTERIZATION, SUBUNIT, AND
RP   MUTAGENESIS OF ASP-201.
RX   PubMed=7711027; DOI=10.1021/bi00015a018;
RA   Serina L., Blondin C., Krin E., Sismeiro O., Danchin A., Sakamoto H.,
RA   Gilles A.-M., Barzu O.;
RT   "Escherichia coli UMP-kinase, a member of the aspartokinase family, is
RT   a hexamer regulated by guanine nucleotides and UTP.";
RL   Biochemistry 34:5066-5074(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=8202364; DOI=10.1093/nar/22.9.1637;
RA   Fujita N., Mori H., Yura T., Ishihama A.;
RT   "Systematic sequencing of the Escherichia coli genome: analysis of the
RT   2.4-4.1 min (110,917-193,643 bp) region.";
RL   Nucleic Acids Res. 22:1637-1639(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RA   Takemoto K., Mori H., Murayama N., Kataoka K., Yano M., Itoh T.,
RA   Yamamoto Y., Inokuchi H., Miki T., Hatada E., Fukuda R., Ichihara S.,
RA   Mizuno T., Makino K., Nakata A., Yura T., Sampei G., Mizobuchi K.;
RT   "Systematic sequencing of the Escherichia coli genome: analysis of the
RT   4.0 - 6.0 min (189,987 - 281,416bp) region.";
RL   Submitted (FEB-1996) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RA   Chung E., Allen E., Araujo R., Aparicio A.M., Davis K., Duncan M.,
RA   Federspiel N., Hyman R., Kalman S., Komp C., Kurdi O., Lew H., Lin D.,
RA   Namath A., Oefner P., Roberts D., Schramm S., Davis R.W.;
RT   "Sequence of minutes 4-25 of Escherichia coli.";
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [9]
RP   CHARACTERIZATION.
RX   PubMed=8190075; DOI=10.1007/BF00283870;
RA   Yamanaka K., Ogura T., Koonin E.V., Niki H., Hiraga S.;
RT   "Multicopy suppressors, mssA and mssB, of an smbA mutation of
RT   Escherichia coli.";
RL   Mol. Gen. Genet. 243:9-16(1994).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=9922246;
RA   Landais S., Gounon P., Laurent-Winter C., Mazie J.-C., Danchin A.,
RA   Barzu O., Sakamoto H.;
RT   "Immunochemical analysis of UMP kinase from Escherichia coli.";
RL   J. Bacteriol. 181:833-840(1999).
RN   [11]
RP   MUTAGENESIS OF ARG-62; ASP-77; ASP-146; ASP-159; ASP-174 AND ASP-201.
RX   PubMed=9457846;
RA   Bucurenci N., Serina L., Zaharia C., Landais S., Danchin A., Barzu O.;
RT   "Mutational analysis of UMP kinase from Escherichia coli.";
RL   J. Bacteriol. 180:473-477(1998).
RN   [12]
RP   ENZYME REGULATION.
RX   PubMed=17210578; DOI=10.1074/jbc.M606963200;
RA   Evrin C., Straut M., Slavova-Azmanova N., Bucurenci N., Onu A.,
RA   Assairi L., Ionescu M., Palibroda N., Barzu O., Gilles A.-M.;
RT   "Regulatory mechanisms differ in UMP kinases from Gram-negative and
RT   Gram-positive bacteria.";
RL   J. Biol. Chem. 282:7242-7253(2007).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF MUTANT ASN-159 IN COMPLEX
RP   WITH UMP; UDP AND UTP, ENZYME REGULATION, AND MUTAGENESIS OF THR-138
RP   AND ASN-140.
RX   PubMed=15857829; DOI=10.1074/jbc.M501849200;
RA   Briozzo P., Evrin C., Meyer P., Assairi L., Joly N., Barzu O.,
RA   Gilles A.-M.;
RT   "Structure of Escherichia coli UMP kinase differs from that of other
RT   nucleoside monophosphate kinases and sheds new light on enzyme
RT   regulation.";
RL   J. Biol. Chem. 280:25533-25540(2005).
CC   -!- FUNCTION: Catalyzes the reversible phosphorylation of UMP to UDP,
CC       with ATP as the most efficient phosphate donor.
CC       {ECO:0000269|PubMed:7711027}.
CC   -!- CATALYTIC ACTIVITY: ATP + UMP = ADP + UDP.
CC   -!- ENZYME REGULATION: Allosterically activated by GTP. Competitively
CC       inhibited by magnesium-free UTP. Magnesium-bound UTP is unable to
CC       inhibit enzyme activity. {ECO:0000269|PubMed:15857829,
CC       ECO:0000269|PubMed:17210578}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=120 uM for ATP {ECO:0000269|PubMed:7711027};
CC         KM=50 uM for UMP {ECO:0000269|PubMed:7711027};
CC         Vmax=96 umol/min/mg enzyme {ECO:0000269|PubMed:7711027};
CC   -!- PATHWAY: Pyrimidine metabolism; CTP biosynthesis via de novo
CC       pathway; UDP from UMP (UMPK route): step 1/1.
CC   -!- SUBUNIT: Homohexamer. {ECO:0000269|PubMed:15857829,
CC       ECO:0000269|PubMed:7711027}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9922246}.
CC       Note=Is predominantly localized near the bacterial membranes.
CC   -!- MISCELLANEOUS: The peripheral distribution of PyrH is related most
CC       probably to its role in the synthesis of membrane sugar
CC       components.
CC   -!- SIMILARITY: Belongs to the UMP kinase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X78809; CAA55388.1; -; Genomic_DNA.
DR   EMBL; D13334; BAA02598.1; -; Genomic_DNA.
DR   EMBL; U70214; AAB08600.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC73282.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAB96747.1; -; Genomic_DNA.
DR   PIR; B45269; B45269.
DR   RefSeq; NP_414713.1; NC_000913.3.
DR   RefSeq; WP_000224573.1; NZ_LN832404.1.
DR   PDB; 2BND; X-ray; 2.60 A; A/B=1-241.
DR   PDB; 2BNE; X-ray; 2.30 A; A/B=1-241.
DR   PDB; 2BNF; X-ray; 2.45 A; A/B=1-241.
DR   PDB; 2V4Y; X-ray; 2.80 A; A/B/C/D/E/F=1-241.
DR   PDBsum; 2BND; -.
DR   PDBsum; 2BNE; -.
DR   PDBsum; 2BNF; -.
DR   PDBsum; 2V4Y; -.
DR   ProteinModelPortal; P0A7E9; -.
DR   SMR; P0A7E9; -.
DR   BioGrid; 4262225; 6.
DR   DIP; DIP-31830N; -.
DR   IntAct; P0A7E9; 54.
DR   MINT; MINT-1222953; -.
DR   STRING; 511145.b0171; -.
DR   EPD; P0A7E9; -.
DR   PaxDb; P0A7E9; -.
DR   PRIDE; P0A7E9; -.
DR   EnsemblBacteria; AAC73282; AAC73282; b0171.
DR   EnsemblBacteria; BAB96747; BAB96747; BAB96747.
DR   GeneID; 944989; -.
DR   KEGG; ecj:JW0166; -.
DR   KEGG; eco:b0171; -.
DR   PATRIC; 32115451; VBIEscCol129921_0177.
DR   EchoBASE; EB1501; -.
DR   EcoGene; EG11539; pyrH.
DR   eggNOG; ENOG4105C41; Bacteria.
DR   eggNOG; COG0528; LUCA.
DR   HOGENOM; HOG000047187; -.
DR   InParanoid; P0A7E9; -.
DR   KO; K09903; -.
DR   OMA; KGLKVMD; -.
DR   PhylomeDB; P0A7E9; -.
DR   BioCyc; EcoCyc:UMPKI-MONOMER; -.
DR   BioCyc; MetaCyc:UMPKI-MONOMER; -.
DR   BRENDA; 2.7.4.22; 2026.
DR   SABIO-RK; P0A7E9; -.
DR   UniPathway; UPA00159; UER00275.
DR   EvolutionaryTrace; P0A7E9; -.
DR   PRO; PR:P0A7E9; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IDA:EcoCyc.
DR   GO; GO:0033862; F:UMP kinase activity; IDA:EcoCyc.
DR   GO; GO:0044210; P:'de novo' CTP biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006221; P:pyrimidine nucleotide biosynthetic process; IDA:EcoCyc.
DR   Gene3D; 3.40.1160.10; -; 1.
DR   HAMAP; MF_01220_B; PyrH_B; 1.
DR   InterPro; IPR001048; Asp/Glu/Uridylate_kinase.
DR   InterPro; IPR011817; Uridylate_kinase.
DR   InterPro; IPR015963; Uridylate_kinase_bac.
DR   PANTHER; PTHR42833:SF2; PTHR42833:SF2; 1.
DR   Pfam; PF00696; AA_kinase; 1.
DR   PIRSF; PIRSF005650; Uridylate_kin; 1.
DR   SUPFAM; SSF53633; SSF53633; 1.
DR   TIGRFAMs; TIGR02075; pyrH_bact; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Allosteric enzyme; ATP-binding; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Kinase; Nucleotide-binding;
KW   Pyrimidine biosynthesis; Reference proteome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:7711027}.
FT   CHAIN         2    241       Uridylate kinase.
FT                                /FTId=PRO_0000143842.
FT   NP_BIND      15     18       ATP. {ECO:0000250}.
FT   NP_BIND     138    145       UMP. {ECO:0000269|PubMed:15857829}.
FT   REGION       23     28       Involved in allosteric activation by GTP.
FT                                {ECO:0000255}.
FT   BINDING      57     57       UMP; via amide nitrogen.
FT                                {ECO:0000269|PubMed:15857829}.
FT   BINDING      58     58       ATP; via amide nitrogen. {ECO:0000250}.
FT   BINDING      62     62       ATP. {ECO:0000250}.
FT   BINDING      77     77       UMP. {ECO:0000269|PubMed:15857829}.
FT   BINDING     165    165       ATP. {ECO:0000250}.
FT   BINDING     171    171       ATP; via amide nitrogen and carbonyl
FT                                oxygen. {ECO:0000250}.
FT   BINDING     174    174       ATP. {ECO:0000250}.
FT   VARIANT      62     62       R -> H (in Smba9).
FT   VARIANT     201    201       D -> N (in Smba2).
FT   MUTAGEN      62     62       R->H: Loss of activation by GTP and
FT                                decreased affinity for UTP.
FT                                {ECO:0000269|PubMed:9457846}.
FT   MUTAGEN      77     77       D->N: Loss of activation by GTP and
FT                                decreased affinity for UTP.
FT                                {ECO:0000269|PubMed:9457846}.
FT   MUTAGEN     138    138       T->A: Loss of activation by GTP. Moderate
FT                                loss of sensitivity to UTP inhibition. 4-
FT                                fold and 2-fold decrease in affinity for
FT                                UMP and ATP, respectively.
FT                                {ECO:0000269|PubMed:15857829}.
FT   MUTAGEN     140    140       N->A: Loss of activation by GTP. Moderate
FT                                loss of sensitivity to UTP inhibition.
FT                                {ECO:0000269|PubMed:15857829}.
FT   MUTAGEN     146    146       D->N: Drastically reduced activity.
FT                                {ECO:0000269|PubMed:9457846}.
FT   MUTAGEN     159    159       D->N: Increased solubility at neutral pH.
FT                                Nearly no change in kinetic properties
FT                                and stability.
FT                                {ECO:0000269|PubMed:9457846}.
FT   MUTAGEN     174    174       D->N: Reduced UMP-binding affinity.
FT                                {ECO:0000269|PubMed:9457846}.
FT   MUTAGEN     201    201       D->N: Loss of activation by GTP.
FT                                {ECO:0000269|PubMed:7711027,
FT                                ECO:0000269|PubMed:9457846}.
FT   CONFLICT     64     69       AGLAKA -> RWSGET (in Ref. 1; CAA55388).
FT                                {ECO:0000305}.
FT   STRAND       10     16       {ECO:0000244|PDB:2BNE}.
FT   HELIX        18     21       {ECO:0000244|PDB:2BNE}.
FT   STRAND       26     28       {ECO:0000244|PDB:2BNE}.
FT   HELIX        31     46       {ECO:0000244|PDB:2BNE}.
FT   STRAND       50     55       {ECO:0000244|PDB:2BNE}.
FT   TURN         58     60       {ECO:0000244|PDB:2BNE}.
FT   HELIX        63     68       {ECO:0000244|PDB:2BNE}.
FT   HELIX        73     97       {ECO:0000244|PDB:2BNE}.
FT   STRAND      102    108       {ECO:0000244|PDB:2BNE}.
FT   TURN        111    113       {ECO:0000244|PDB:2BNE}.
FT   STRAND      114    116       {ECO:0000244|PDB:2BNE}.
FT   HELIX       119    127       {ECO:0000244|PDB:2BNE}.
FT   STRAND      131    136       {ECO:0000244|PDB:2BNE}.
FT   STRAND      139    142       {ECO:0000244|PDB:2BNF}.
FT   HELIX       145    155       {ECO:0000244|PDB:2BNE}.
FT   STRAND      159    169       {ECO:0000244|PDB:2BNE}.
FT   STRAND      171    173       {ECO:0000244|PDB:2BNE}.
FT   TURN        175    177       {ECO:0000244|PDB:2BND}.
FT   STRAND      185    188       {ECO:0000244|PDB:2BNE}.
FT   HELIX       189    194       {ECO:0000244|PDB:2BNE}.
FT   HELIX       202    210       {ECO:0000244|PDB:2BNE}.
FT   STRAND      215    219       {ECO:0000244|PDB:2BNE}.
FT   HELIX       225    230       {ECO:0000244|PDB:2BNE}.
FT   STRAND      236    240       {ECO:0000244|PDB:2BNE}.
SQ   SEQUENCE   241 AA;  25970 MW;  82EFA75F7226E201 CRC64;
     MATNAKPVYK RILLKLSGEA LQGTEGFGID ASILDRMAQE IKELVELGIQ VGVVIGGGNL
     FRGAGLAKAG MNRVVGDHMG MLATVMNGLA MRDALHRAYV NARLMSAIPL NGVCDSYSWA
     EAISLLRNNR VVILSAGTGN PFFTTDSAAC LRGIEIEADV VLKATKVDGV FTADPAKDPT
     ATMYEQLTYS EVLEKELKVM DLAAFTLARD HKLPIRVFNM NKPGALRRVV MGEKEGTLIT
     E
//
